Who owns Protagonist Therapeutics, Inc?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PTGX from SEC Form 13F filings across 380 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 380 institutions disclosed 77.3M shares of Protagonist Therapeutics, Inc worth $10.89B — about 116.5% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
380
13F holders
$10.89B
value, 2026 filers
116.5%
of shares outstanding (77.3M sh)
80
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of PTGX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 10.7M | $1.51B | 0.0% | 16.2% | +4.1% |
| 2 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 6.4M | $907.0M | 3.9% | 9.7% | +1.4% |
| 3 | RTW INVESTMENTS, LP | 5.1M | $713.1M | 7.2% | 7.6% | 0.0% |
| 4 | UBS Group AG | 4.0M | $557.0M | 0.1% | 6% | +16.3% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.7M | $516.9M | 0.0% | 5.5% | +1.1% |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | 3.5M | $499.3M | 0.1% | 5.3% | +3.7% |
| 7 | STATE STREET CORP | 3.5M | $490.2M | 0.0% | 5.2% | +4.7% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 2.9M | $407.9M | 0.0% | 4.4% | +1.5% |
| 9 | Invesco Ltd. | 2.8M | $399.7M | 0.0% | 4.3% | +21.2% |
| 10 | JOHNSON & JOHNSON | 2.4M | $345.1M | 45.3% | 3.7% | 0.0% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 1.8M | $253.7M | 0.0% | 2.7% | +3.4% |
| 12 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.8M | $253.5M | 0.0% | 2.7% | -16.3% |
| 13 | Janus Henderson Group Ltd.NEW | 1.6M | $221.2M | 0.1% | 2.4% | new |
| 14 | Woodline Partners LP | 1.4M | $198.6M | 0.6% | 2.1% | -0.3% |
| 15 | BANK OF AMERICA CORP /DE/ | 1.4M | $193.4M | 0.0% | 2.1% | +3.6% |
| 16 | FMR LLC | 1.1M | $151.6M | 0.0% | 1.6% | +60.1% |
| 17 | GOLDMAN SACHS GROUP INC | 953,466 | $134.3M | 0.0% | 1.4% | +17.3% |
| 18 | ADAR1 Capital Management, LLC | 951,403 | $134.0M | 6.1% | 1.4% | -1.0% |
| 19 | Hood River Capital Management LLC | 893,479 | $125.9M | 1.1% | 1.3% | +1.2% |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 881,579 | $124.2M | 0.0% | 1.3% | +51.0% |
| 21 | Clearbridge Investments, LLC | 877,144 | $123.6M | 0.1% | 1.3% | +20.9% |
| 22 | PERCEPTIVE ADVISORS LLC | 836,579 | $117.9M | 2.1% | 1.3% | -14.8% |
| 23 | JENNISON ASSOCIATES LLC | 833,488 | $117.4M | 0.1% | 1.3% | -27.6% |
| 24 | MORGAN STANLEY | 763,397 | $107.6M | 0.0% | 1.2% | -15.7% |
| 25 | Driehaus Capital Management LLC | 676,824 | $95.4M | 0.7% | 1% | -7.4% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.